Blog

  • India’s biofuel drive is saving billions but also sparking worries

    India’s biofuel drive is saving billions but also sparking worries

    Getty Images A petrol pump worker, in a saffron dress, putting fuel in a bike. The pumping machine can be seen in the background.

Getty Images

    Indian government says ethanol blending has cut 69.8 million tonnes of carbon dioxide emissions since 2014

    India’s drive to blend more biofuels with petrol has helped the country cut millions of tonnes of carbon dioxide emissions and save precious dollar reserves.

    But it has also sparked worries among vehicle owners and food policy experts about its potential impact on fuel efficiency and food security.

    Last month, India achieved its objective of blending 20% ethanol with petrol, known as E20, five years ahead of its target.

    The government views this as a game changer in reducing carbon emissions and trimming oil imports. Since 2014, ethanol blending has helped India cut 69.8 million tonnes of carbon dioxide emissions and saved 1.36 trillion rupees ($1.5 bn; £1.1 bn) in foreign exchange.

    A study by Delhi-based think tank Council on Energy, Environment and Water (CEEW) shows that carbon dioxide emissions from road transport in India will nearly double by 2050.

    “The demand for fuel is only going to increase and shifting to ethanol-blended petrol is absolutely necessary to cut down emissions,” Sandeep Theng from the Indian Federation of Green Energy, an organisation that promotes green energy, told the BBC.

    But many vehicles in India are not E20-compliant, making their owners sceptical about the benefits of the policy.

    Hormazd Sorabjee, editor of Autocar India magazine, said that ethanol has a “lower energy density than petrol and is more corrosive”. This results in lower mileage and exposes certain vehicle parts to a greater risk of wear and tear.

    Mr Sorabjee added that some manufacturers like Honda have been using E20 compliant material since 2009, but many older vehicles on Indian roads are not E20 compatible.

    While there is no official data on the impact of of E20 fuel on engines, consumers routinely share anecdotes about their vehicle’s deteriorating mileage on social media.

    Many standard insurance policies in India also don’t provide cover for damage due to the use of non-compliant fuel, a top executive at online insurance platform Policybazaar, who wanted to stay anonymous, told the BBC.

    “Consumers need to take add-on policies but even those claims can be denied or downgraded based on fine print of the policy,” he added.

    The federal petroleum ministry has described these concerns as “largely unfounded”.

    In a post on X, the ministry said that engine tuning and E20-compatible materials could minimise the drop in mileage. It also advised replacing certain parts in older vehicles, saying the process was inexpensive and “easily done during regular servicing of the vehicle”.

    Getty Images A worker, wearing turquoise-white checked shirt and blue jeans, inside a factory, working with stubble. 
Getty Images

    Expansion of ethanol use could mean diverting more farm produce into manufacturing fuel

    Mr Sorabjee told the BBC that while milage concerns are real, they are a “not always as bad as made out to be”.

    The bigger concern, he said, was the potential damage to vehicle materials due to the corrosive properties of E20.

    Some vehicle manufacturers are offering ways to mitigate this.

    Maruti Suzuki, India’s biggest four-wheeler maker, is reportedly likely to introduce an E20 material kit that could cost up to 6,000 rupees ($69; £51). The kit will reportedly replace components like fuel lines, seals and gaskets. Bajaj, a leading Indian two-wheeler maker, has advised using a fuel cleaner that could cost around 100 rupees ($1.15; £0.85) for a full tank of petrol.

    But not all vehicle-owners are convinced. Amit Pandhi, who has owned a Maruti Suzuki car in Delhi since 2017, is unhappy that petrol pumps don’t offer the choice to opt for a blend other than E20.

    “Why should I be forced to buy petrol that offers less mileage and then spend more to make the materials compliant?” he asked.

    In 2021, a document on India’s transition to E20 published by Niti Aayog, a government think tank, had highlighted some of these concerns. It recommended tax benefits for buying E20 compliant vehicles, along with a lower retail price for the fuel.

    The government has defended its decision to not pass the recommendations, saying that at the time of the report’s relase, ethanol was cheaper than petrol.

    “Over time, procurement price of ethanol has increased and now the weighted average price of ethanol is higher than cost of refined petrol,” the petroleum ministry said earlier this month.

    Getty Images India's federal Minister of Petroleum and Natural Gas Hardeep Singh Puri, wearing blue jacket and turban, with his hand raised, is addressing a gathering. Getty Images

    India is looking to increase ethanol-blending in petrol in the coming years

    It’s not just consumers – the government’s blended fuel push has also raised concern among climate researchers and food policy experts.

    Ethanol is produced from crops like sugarcane and maize, and expanding its use means diverting farm produce into manufacturing more fuel.

    In 2025, India would need 10 billion litres of ethanol to meet its E20 requirements, according to government estimates. The demand will balloon to 20 billion litres by 2050, according to Bengaluru-based think tank Center for Study of Science, Technology and Policy (CSTEP).

    Right now, sugarcane is used to produce about 40% of India’s ethanol.

    This puts India in a bind. It has to choose between continuing its reliance on sugarcane – which has a higher yield for ethanol but is water-intensive – or using food crops like maize and rice to produce the fuel.

    But the shift comes with its own challenges.

    In 2024, for the first time in decades, India became a net importer of maize, using large amounts of the crop to make ethanol.

    Ramya Natarajan, a research scientist at CSTEP, said the diversion of produce had a significant impact on the poultry sector, which now has to spend more to buy corn for feedstock.

    Moreover, this year, the Food Corporation of India (FCI) approved an unprecedented allocation of 5.2 million tonnes of rice for ethanol production. The rice in FCI stocks is earmarked to be given to India’s poor at a subsidised rate.

    The policy could lead to an “agriculture disaster in a couple of years”, said Devinder Sharma, a farming sector expert.

    “In a country like India, where 250 million people go hungry, we cannot use food to feed the cars,” Mr Sharma said.

    To meet the demand for ethanol through corn and sugarcane in a 50-50 ratio – as outlined by Niti Aayog – India would have to bring in an additional eight million hectares of land under maize cultivation by 2030, unless there is a drastic increase in yield, according to CSTEP.

    But even that could lead to problems.

    “If farmers replace rice or wheat cultivation with maize, that would be sustainable because we have enough surplus of these crops. But we need other crops like oilseeds and pulses too,” Ms Natarajan said.

    Ms Natarajan added that continuing with the E10 blend – petrol mixed with 10% ethanol – would have been a more ideal choice.

    India, however, is planning to go even beyond E20.

    “The country will now gradually scale towards E25, E27, and E30 in a phased, calibrated manner,” Petroleum Minister Hardeep Puri said recently.

    Follow BBC News India on Instagram, YouTube, X and Facebook


    Continue Reading

  • ‘The Summer I Turned Pretty’ actor breaks down latest episode of series

    ‘The Summer I Turned Pretty’ actor breaks down latest episode of series



    The Summer I Turned Pretty’s Sean Kaufman opens up about the latest episode

    The Summer I Turned Pretty’s Sean Kaufman is opening up about the latest episode, weighing in on the debate surrounding the show’s ‘stressful’ love triangle.

    Kaufman, who portrays Steven in the series, is getting candid about the romantic dilemma in the third and final season.

    During an exclusive interview with People magazine, the actor recently explained why he found himself torn between the two women in his life.

    He told the outlet, “I had no idea what to expect. When we started season 3, we weren’t given all the scripts, so to go episode by episode and see how it plays out, and see the love triangle start to form, was very interesting and fun.”

    The 25-year-old broke down the latest episode, revealing how the love story begins to wrap up in the final installment of the series.

    Speaking about the August 20 episode, Kaufman said, “Yeah, it’s a big one. It’s the first time you see the dynamic between the three of them.”

    For those unfamiliar, the actor stars alongside Rain Spencer and Denise in the series’ central love triangle.

    Continue Reading

  • Google Beats Apple in Smartphone AI Race

    Google Beats Apple in Smartphone AI Race

    Apple is behind Google in the race to add artificial intelligence (AI) features to smartphones, according to Wall Street Journal Personal Tech Columnist Nicole Nguyen.

    An iPhone user, Nguyen wrote Wednesday (Aug. 20) that her experience with Google’s upcoming Pixel 10 showed that Google has “lapped” Apple as both companies work to develop the “killer AI-powered phone.”

    Nguyen highlighted the Pixel 10’s AI-powered ability to surface information when needed, provide translations via a real-time voice clone and transcript, coach users to take good photos, and edit photos that have already been taken.

    “The race continues and for now, Apple has a lot of catching up to do,” Nguyen wrote.

    Apple did not immediately reply to PYMNTS’ request for comment.

    PYMNTS CEO Karen Webster wrote July 23 that Apple faces the risk of its iPhone becoming a commodity because the Pixel 9 has, and Pixel 10 will ship with, embedded AI that lets users speak, search, transact and navigate with a native AI experience.

    “Apple can’t match that today,” Webster wrote. “The risk is how many consumers will keep waiting around for Apple to deliver. It’s a massive pain to switch from iOS to Android devices, and most people don’t. Getting an AI-powered Android device just may be enough for people to dump their iPhones.”

    Apple has faced AI challenges that include investor impatience, talent departures and delayed Siri upgrades, as PYMNTS has chronicled in recent months.

    It was reported Aug. 14 that the company is preparing a comeback in the AI space that includes a redesigned Siri powered by large language models, which could potentially arrive on iPhones and iPads as early as next year.

    Apple’s hardware pipeline also includes thinner iPhones this year.

    On Aug. 4, it was reported that Apple held a rare companywide meeting to cover its investment in AI and that CEO Tim Cook expressed a positive outlook about the company’s AI future.

    According to the report, Cook told workers that Apple has “exciting” plans for AI that he wasn’t able to discuss.

    Earlier, during an earnings call, Cook said the company is making “good progress” on integrating more AI capabilities in Siri.

    Continue Reading

  • CJ rejects delay in Imran bail hearings

    CJ rejects delay in Imran bail hearings


    ISLAMABAD:

    Chief Justice Yahya Afridi on Wednesday made it clear that the Supreme Court would not allow prolonged adjournments in the bail petitions of PTI founder Imran Khan, being heard in connection with multiple cases linked to the May 9, 2023 violence.

    A three-member bench led by Chief Justice Afridi, and including Muhammad Shafi Siddiqui and Justice Miangul Hasan Aurangzeb, took up appeals against the Lahore High Court’s (LHC) June 24 decision, in which a bench led by Justice Shahbaz Ali Rizvi had dismissed Imran’s bail applications.

    During the proceedings, the chief justice observed that the prosecution would first have to cross the threshold of establishing how the LHC’s rejection of the bail could be sustained. “We will hear the prosecution first,” he remarked.

    The hearing began with an assisting counsel informing the bench that Special Prosecutor Zulfiqar Naqvi could not appear due to food poisoning and was currently admitted to a hospital. He requested the matter be adjourned until next week.

    The chief justice, however, responded that the matter would be taken up on Thursday (today). Advocate Salman Safdar, representing the PTI founder, objected to the adjournment request and urged the court to at least allow them to argue.

    He pointed out that the LHC had dismissed his client’s bail plea in November last year after six months of pendency, during which 16 hearings were held and eight different prosecutors were changed. “The prosecution repeatedly sought adjournments. We are now fed up,” he said.

    Chief Justice Afridi assured the defence that the matter would not be subjected to unnecessary delays. Advocate Safdar requested that family members of the PTI founder, who were present in court, be allowed to address the bench.

    However, the chief justice declined the request, stating: “We will only hear the lawyer. We will not allow family members to speak in court.” The hearing was attended by the PTI founder’s sisters along with senior party leaders. Later, the bench adjourned further proceedings until Thursday (today).

    In their detailed verdict, LHC’s Justice Syed Shahbaz Ali Rizvi and Justice Tariq Mahmood Bajwa had said: “In this view of the matter argument furnished by learned counsel for the petitioner (Imran Khan) to the effect that on May 9, 2023, the petitioner was in jail is of no help to him.”

    In its detailed verdict, the bench reproduced the statements of two police officials, the prosecution witnesses, who claimed to have secretly attended the meetings of the PTI wherein the party’s founder allegedly gave instructions to other party leaders to attack military installations in case of his imminent arrest from the IHC.

    The bench observed that the statements of the witnesses were not to be termed as belated.

    It said the role assigned to the petitioner, evident from the statements of the witnesses, attracted the provisions of Section 120-B (punishment for criminal conspiracy) and 121-A (conspiracy to commit offence of waging or attempting to wage war against the country) of the Pakistan Penal Code.

    The bench held that the statements of the witnesses prima facie reflected that the conspiracy and abetment for the offences committed on May 9 were perpetrated by the petitioner on May 4 at Chakri rest area, Rawalpindi, on May 7 and on May 9 at Lahore.

    Continue Reading

  • Strong commercial performance enables investment for long-term growth

    Strong commercial performance enables investment for long-term growth

    Telix Therapeutics: Reinvesting earnings to accelerate late-stage pipeline

    Of the total R&D investment, 54% ($43.9 million) was invested in the therapeutics pipeline. Milestones achieved include:

    • TLX591 (177Lu-rosopatamab tetraxetan): Completed target enrollment of 30 patients for Part 1 of the Phase 3 study in advanced metastatic castration resistant prostate cancer (mCRPC). The trial has received regulatory approval to proceed in Australia, China, Canada, New Zealand, Turkey and Japan.

    • TLX592 (225Ac-PSMA-RADmAb): Approval to commence a Phase 1, first-in-human therapeutic study of a targeted alpha therapy in advanced mCRPC.

    • TLX101 (131I-iodofalan, or 131I-IPA): Approval to commence IPAX BrIGHT, an international pivotal trial, to commence at Australian sites initially.

    • TLX090 (153Sm-DOTMP): Investigational New Drug (IND) application approved for a Phase 1 bridging study for Telix’s therapeutic candidate for the palliation of bone pain in patients with osteoblastic metastatic disease to the bone.

    Commentary

    Managing Director and Group CEO, Dr. Christian Behrenbruch, commented on the result:

    “Telix continues to deliver strong revenue growth while building a foundation for the future. The first half of 2025 was a period of rapid transformation as we expanded our global manufacturing operations, invested in launching new products in new markets, and accelerated the development of our therapeutic pipeline. These investments have positioned Telix for sustainable, long-term growth, while our diversified business provides multiple drivers of success. To generate future revenue growth, we are confident in securing product approvals for Pixclara and Zircaix while advancing geographic and indication expansion for the PSMA portfolio.”

    Summary Group financial results

     

    H1 2025

    H1 2024

     

    US$M

    US$M

    Revenue

    390.4

     

    239.6

     

    Cost of sales

    (181.8

    )

    (82.4

    )

    Gross profit

    208.6

     

    157.2

     

    Research and development (R&D)

    (81.6

    )

    (55.4

    )

    Selling and marketing

    (49.0

    )

    (24.6

    )

    Manufacturing and distribution

    (18.8

    )

    (8.4

    )

    General and administration

    (47.7

    )

    (39.2

    )

    Other losses (net)

    (1.1

    )

    (1.9

    )

    Operating profit

    10.4

     

    27.7

     

    Finance income

    3.6

     

    0.9

     

    Finance costs

    (18.8

    )

    (5.7

    )

    (Loss)/profit before tax

    (4.8

    )

    22.9

     

    Adjusted EBITDA

    21.1

     

    37.1

     

    Cash from operating activities

    17.7

     

    23.3

     


    Guidance

    • Telix confirms FY 2025 revenue guidance of US$770 million to US$800 million11.

    • Guidance reflects revenue from Illuccix sales in jurisdictions with a marketing authorization, and 11 months of revenue contribution from RLS12.

    • Telix confirms R&D expenditure guidance, expecting a year-over-year increased investment range for FY 2025 of 20% to 25% compared to FY 2024.

    lnvestor call

    An investor webcast and conference call will be held at 9.30am AEST on Thursday 21 August 2025 (7.30pm EDT Wednesday 20 August 2025).

    Participants can register for the webcast by clicking here: https://edge.media-server.com/mmc/p/x4gytx8w/ or the teleconference here: https://s1.c-conf.com/diamondpass/10049152-x745re.html

    About Telix Pharmaceuticals Limited

    Telix is a biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. Telix is headquartered in Melbourne, Australia, with international operations in the United States, United Kingdom, Canada, Europe (Belgium and Switzerland), Brazil and Japan. Telix is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Telix is listed on the Australian Securities Exchange (ASX: TLX) and the Nasdaq Global Select Market (NASDAQ: TLX).

    Visit www.telixpharma.com for further information about Telix, including details of the latest share price, ASX and U.S. Securities and Exchange Commission (SEC) filings, investor and analyst presentations, news releases, event details and other publications that may be of interest. You can also follow Telix on LinkedIn, X and Facebook.

    Telix Investor Relations (Global)

    Ms. Kyahn Williamson
    Telix Pharmaceuticals Limited
    SVP Investor Relations and Corporate Communications
    Email: kyahn.williamson@telixpharma.com

    Telix Investor Relations (U.S.)

    Ms. Annie Kasparian
    Telix Pharmaceuticals Limited
    Director Investor Relations and Corporate Communications
    Email: annie.kasparian@telixpharma.com

    Guidance Disclaimer

    The stated revenue guidance is based on expected global and domestic economic conditions and is subject to known and unknown risks, uncertainties and other factors that may cause our actual results to differ materially. As such, investors are cautioned not to place undue reliance on this guidance and in particular Telix cannot guarantee a particular result. In compiling financial forecasts, a number of key variables that may have a significant impact on guidance have been identified and are listed below.

    Key variables that could cause actual results to differ materially include: the success and timing of research and development activities; decisions by regulatory authorities regarding approval of our products as well as their decisions regarding label claims; competitive developments affecting our products; the ability to successfully market new and existing products; difficulties or delays in manufacturing; trade buying patterns and fluctuations in interest and currency exchange rates; legislation or regulations that affect product production, distribution, pricing, reimbursement, access or tax; acquisitions and divestitures; research collaborations; litigation or government investigations; and Telix’s ability to protect its patents and other intellectual property.

    This announcement has been authorized for release by the Telix Pharmaceuticals Limited Board of Directors

    Legal Notices

    Cautionary Statement Regarding Forward-Looking Statements.

    You should read this announcement together with our risk factors, as disclosed in our most recently filed reports with the Australian Securities Exchange (ASX), U.S. Securities and Exchange Commission (SEC), including our Annual Report on Form 20-F filed with the SEC, or on our website.

    The information contained in this announcement is not intended to be an offer for subscription, invitation or recommendation with respect to securities of Telix Pharmaceuticals Limited (Telix) in any jurisdiction, including the United States. The information and opinions contained in this announcement are subject to change without notification. To the maximum extent permitted by law, Telix disclaims any obligation or undertaking to update or revise any information or opinions contained in this announcement, including any forward-looking statements (as referred to below), whether as a result of new information, future developments, a change in expectations or assumptions, or otherwise. No representation or warranty, express or implied, is made in relation to the accuracy or completeness of the information contained or opinions expressed in the course of this announcement.

    This announcement may contain forward-looking statements, including within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, that relate to anticipated future events, financial performance, plans, strategies or business developments. Forward-looking statements can generally be identified by the use of words such as “may”, “expect”, “intend”, “plan”, “estimate”, “anticipate”, “believe”, “outlook”, “forecast” and “guidance”, or the negative of these words or other similar terms or expressions. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements are based on Telix’s good-faith assumptions as to the financial, market, regulatory and other risks and considerations that exist and affect Telix’s business and operations in the future and there can be no assurance that any of the assumptions will prove to be correct. In the context
    of Telix’s business, forward-looking statements may include, but are not limited to, statements about: the initiation, timing, progress, completion and results of Telix’s preclinical and clinical trials, and Telix’s research and development programs; Telix’s ability to advance product candidates into, enroll and successfully complete, clinical studies, including multi-national clinical trials; the timing or likelihood of regulatory filings and approvals for Telix’s product candidates, manufacturing activities and product marketing activities; Telix’s sales, marketing and distribution and manufacturing capabilities and strategies; the commercialization of Telix’s product candidates, if or when they have been approved; Telix’s ability to obtain an adequate supply of raw materials at reasonable costs for its products and product candidates; estimates of Telix’s expenses, future revenues and capital requirements; Telix’s financial performance; developments relating to Telix’s competitors and industry; the anticipated impact of U.S. and foreign tariffs and other macroeconomic conditions on Telix’s business; and the pricing and reimbursement of Telix’s product candidates, if and after they have been approved. Telix’s actual results, performance or achievements may be materially different from those which may be expressed or implied by such statements, and the differences may be adverse. Accordingly, you should not place undue reliance on these forward-looking statements.

    Trademarks and Trade Names. All trademarks and trade names referenced in this press release are the property of Telix Pharmaceuticals Limited (Telix) or, where applicable, the property of their respective owners. For convenience, trademarks and trade names may appear without the ® or ™ symbols. Such omissions are not intended to indicate any waiver of rights by Telix or the respective owners. Trademark registration status may vary from country to country. Telix does not intend the use or display of any third-party trademarks or trade names to imply any affiliation with, endorsement by, or sponsorship from those third parties.

    ©2025 Telix Pharmaceuticals Limited. All rights reserved.

    1. See summary Group financial results table at end of this document.

    2. Group performance includes Telix Precision Medicine, Telix Therapeutics and Telix Manufacturing Solutions (TMS).

    3. All comparisons to H1 2024 results.

    4. FY 2025 revenue guidance of US$770 million to US$800 million.

    5. Earnings before interest, tax, depreciation and amortization.

    6. Increased investment range for FY 2025 expected to be 20% to 25% compared to FY 2024.

    7. Launch and brand names subject to final regulatory approval.

    8. RLS network is comprised of 28 locations across the U.S.

    9. Positron emission tomography.

    10. Single photon emission computed tomography.

    11. Refer to ASX disclosures 20 February 2025.

    12. See Guidance Disclaimer for further information.

    Continue Reading

  • This surprising gas could be causing deep seafloor earthquakes

    This surprising gas could be causing deep seafloor earthquakes

    Deep beneath the Mid-Atlantic Ridge, scientists have recorded earthquakes at roughly 6 to 12 miles below the seafloor, far deeper than where rock should normally crack. The finding points to a new driver of seismicity far from familiar fault zones and volcanoes.

    The culprit is not extra cold rock or a hidden megafault. It looks like carbon dioxide in hot mantle melt changing volume as pressure drops, a physical nudge that can make rock fail at depth.

    Deep seafloor earthquakes


    A research team deployed ocean-bottom seismometers, autonomous instruments that sit on the seafloor and record tiny vibrations, during the SMARTIES campaign in 2019.

    Those sensors captured clusters of microearthquakes in the warm mantle directly under the ridge axis, well below the usual brittle layer. 

    The work was led by Satish C. Singh of the Institut de Physique du Globe de Paris (IPGB), a group with decades of experience imaging the oceanic crust and mantle.

    In this study, the team focused on a slow-spreading equatorial ridge segment where seismic activity is usually modest.

    Geochemical analyses of nearby basalts showed unusually high carbon dioxide in the primary melts, about 0.4 to 3.0 percent by weight. That enrichment is consistent with melts derived from a mantle source that carries extra volatiles. 

    The earthquakes sit at depths where temperatures are expected to be too high for rock to break in a brittle way. That mismatch pushed the team to look beyond temperature or fault geometry and consider the physical effects of gases in magma.

    How CO2 triggers seafloor earthquakes

    Degassing changes the volume of a fluid, and in a confined rock, even small pressure shifts can matter.

    The solubility of CO2 in basaltic melt depends strongly on pressure, so as melt rises and pressure falls, bubbles form and the melt expands. 

    At depth, CO2 can stay dissolved at high concentrations, then separate as a gas as pressure eases, a process that stiffens and relaxes stresses along cracks in quick bursts.

    Volatile solubility studies show this pressure control is a first-order effect in mafic magmas. 

    Seismologists often use mantle temperatures around 700 to 900 degrees Celsius as a practical ceiling for where brittle failure can occur, which puts these Atlantic events in notably hot conditions.

    That is why a stress source tied to expanding gas, not a cold, thick lid, better fits the observations.

    Why it matters for ocean crust

    Volatiles do more than spark eruptions at volcanoes on land. They lower melting temperatures, steer where melts collect, and change how the new ocean crust forms beneath spreading ridges.

    The Atlantic results suggest volatiles can also shape where and how earthquakes happen in the mantle beneath ridges. 

    If CO2 rich melts stall in the mantle before feeding the crust, they can evolve chemically and mechanically at depth.

    That pause can increase heterogeneity in the lithosphere, the rigid outer shell, and near the asthenosphere, the weaker layer below it.

    The study also helps explain seismic reflections and partial melt hints right at the lithosphere, asthenosphere boundary in the equatorial Atlantic.

    Independent work indicates that a small percentage of melt, aided by volatiles, can persist there at temperatures below the dry peridotite solidus.

    What makes this different from volcano swarms

    Deep earthquakes linked to magma motion show up in active volcanic zones like Iceland’s Reykjanes Peninsula.

    There, researchers documented deep long period events at about 6 to 7 miles depth around the 2021 Fagradalsfjall eruption, a very different tectonic setting. 

    Off Mayotte in the Indian Ocean, a seismic crisis revealed drainage of a huge reservoir from roughly 15 to 22 miles down, accompanied by deformation and very long period signals.

    That sequence pointed to a developing submarine volcano rather than steady ridge accretion.

    In Iceland’s Northern Volcanic Zone, several nests of unusually deep quakes, sometimes deeper than 20 miles, are tied to magma movement below the usual brittle layer.

    Those cases involve thickened crust and a volcanic plumbing system, unlike the Atlantic ridge segment studied here.

    Fresh look at volatile-rich ridges

    The Atlantic ridge segment examined spreads slowly, a regime where melt pathways are complex and tectonics can expose mantle rocks on the seafloor.

    In such settings, volatile rich melts may focus and linger, priming the conditions for gas driven stress changes at depth.

    Global ridge studies show that mid ocean ridge basalt glasses are commonly depleted in CO2 by the time they erupt, which complicates efforts to reconstruct their original volatile content.

    Trace element ratios such as CO2 to Ba and CO2 to Rb provide workarounds to estimate the pre-eruptive load.

    More deep seafloor earthquakes studies

    Better constraints on volatile content and pressure in the mantle will come from longer deployments and denser arrays of seafloor instruments.

    Targeted sampling of fresh basalts and melt inclusions will tighten the links between chemistry, pressure, and the mechanics of these deep events.

    Models that couple gas solubility, fracture mechanics, and ridge thermal structure can test how much CO2 is needed to tip rock into failure in hot mantle.

    Those models can also explain why only some ridge segments host deep quakes while others stay quiet.

    The study is published in Nature Communications.

    —–

    Like what you read? Subscribe to our newsletter for engaging articles, exclusive content, and the latest updates. 

    Check us out on EarthSnap, a free app brought to you by Eric Ralls and Earth.com.

    —–

    Continue Reading

  • Beijing turns against Nvidia’s AI chip after ‘insulting’ Lutnick remarks

    Beijing turns against Nvidia’s AI chip after ‘insulting’ Lutnick remarks

    Beijing’s move to restrict sales of Nvidia’s China-specific artificial intelligence processor was prompted by remarks from US commerce secretary Howard Lutnick about chip exports that officials found “insulting”.

    A group of Chinese regulators have mobilised in an effort to dissuade domestic tech companies from acquiring the H20 — a watered-down processor widely used for artificial intelligence in China.

    According to people with knowledge of the regulatory action, the Cyberspace Administration of China (CAC), the National Development and Reform Commission (NDRC) and the Ministry of Industry and Information Technology (MIIT) moved in response to comments made by Lutnick last month.

    “We don’t sell them our best stuff, not our second-best stuff, not even our third-best,” Lutnick told CNBC on July 15, the day after the Trump administration lifted export controls, implemented in April, on H20 sales.

    “You want to sell the Chinese enough that their developers get addicted to the American technology stack, that’s the thinking,” he added.

    Some of China’s senior leaders found the comments “insulting”, leading to the policymakers to seek ways to restrict Chinese tech firms from buying the processors, according to two people with knowledge of the latest regulatory decision-making.

    As a result, Chinese tech groups held off or significantly downsized their H20 orders, according to those with knowledge of their plans.

    The moves have come as a blow to Nvidia, whose chief executive Jensen Huang last month visited Beijing and committed to stay competitive in the country despite growing geopolitical tensions with the US.

    Following Huang’s warmly received trip, Nvidia received sufficient interest from Chinese clients that it told fabrication partner TSMC to reopen its H20 production lines, according to two people with knowledge of the matter.

    Chinese regulators have urged more use of domestic chips in recent years, but tech giants from Alibaba to ByteDance argued that their AI development would be impaired without Nvidia’s chips, hurting China’s chance to win the technology arms race with the US.

    However, some close to the tech companies said they have now become more accepting of a switch, especially for “inference”, in which AI systems respond to requests from users.

    That shift came after testing and adopting chips from domestic producers led by Huawei and Cambricon at a larger scale, following Washington’s initial April ban on exporting Nvidia’s H20s. 

    “Lutnick’s speech gives the coalition [of regulators] one more reason to intensify its efforts to push tech firms to use China’s own chips,” said a person close to the policymakers.

    A week after his comments, China’s internet regulator CAC issued so-called “window guidance” — an informal notice — to major tech firms such as ByteDance and Alibaba, citing security concerns and instructing them to halt new orders for Nvidia’s H20 chips, according to people with knowledge of the regulator’s effort.

    On July 31, the agency summoned Nvidia executives over alleged “serious security issues”. In a statement, the CAC claimed that US AI experts had revealed Nvidia’s chips have location tracking and can be shut down remotely — a claim strongly disputed by Nvidia.

    MIIT, China’s regulator of telecoms and software, also spoke with Chinese tech executives informally to echo CAC’s stance, according to one of the people with knowledge of the meetings.

    The NDRC, China’s state planner that is in charge of the country’s drive for tech independence, then issued its own window guidance, requesting that tech firms refrain from purchasing all Nvidia chips, including the H20, said those with knowledge of the move.

    NDRC has been for years tasked with promoting chip independence and helping domestic players such as Huawei to capture market share from Nvidia.

    The new involvement of CAC in particular has created more pressure for Chinese tech giants to comply, even if the instructions remain informal, as any potential penalties from the watchdog would choke their daily operations.

    These actions are in sharp contrast to other Chinese departments, such as the commerce and foreign affairs ministries, which have been more open to Nvidia’s business, according to industry insiders.

    The two ministries, which are also in charge of trade negotiations with the US, welcomed Huang in July as a positive signal for foreign businesses and to show Beijing’s goodwill in the ongoing trade talks, the people said.

    “A lot of uncertainties remain depending on trade negotiations and Washington’s next moves,” said one of the people. “The fact that all current restrictive guidance from various regulators remain informal provides some room for future changes.”

    Despite some Washington officials and lawmakers seeking stronger chip curbs, President Trump has said he could potentially allow a downgraded Nvidia Blackwell chip to be exported to China in addition to H20.

    Some Chinese tech companies have held off their H20 orders also because they want see if the China specific Blackwell chip, which potentially has better performance than H20, would become available, according to people with knowledge of their thinking.

    Some Beijing policymakers are pushing to ban foreign chips altogether for inference, which accounts for most AI demand, according to a person recently summoned for a meeting with them.

    That is unlikely to happen soon due to a shortage of domestic chip supplies, which Beijing hopes to significantly improve by next year when several advanced production lines are scheduled to launch.

    China’s foreign ministry said: “As a matter of principle, science, technology, and economic and trade issues should not be politicised, instrumentalised, or weaponised. Containment and suppression will not hold back China’s development.”

    Other Chinese regulators and ministries did not respond to questions for comment. Alibaba and ByteDance did not answer emails requesting comment. The US Commerce department did not immediately respond to a request for comment. Nvidia declined to comment.

    Additional reporting from Michael Acton in San Francisco and Eleanor Olcott in Beijing

    Continue Reading

  • 140,000-year-old fossil shows human–Neanderthal interbreeding

    140,000-year-old fossil shows human–Neanderthal interbreeding

    An international research team has identified the earliest fossil showing both Neanderthal and Homo sapiens traits.

    The skeleton, belonging to a five-year-old child found 90 years ago in Israel’s Skhul Cave, dates back about 140,000 years. Researchers say the discovery is the first physical proof that the two groups interbred in the region far earlier than previously believed.

    Neanderthal and human traits

    The study was led by Prof. Israel Hershkovitz of Tel Aviv University and Anne Dambricourt-Malassé of the French National Centre for Scientific Research. Their team analyzed the child’s skull and jaw with advanced micro-CT scans.

    The results showed a mix of features. The skull vault curved like that of Homo sapiens. But the intracranial blood supply system, lower jaw, and inner ear structure resembled Neanderthals.

    “This discovery reveals the world’s earliest known human fossil showing morphological traits of both of these human groups,” the researchers said. They added that the skeleton is “the result of continuous genetic infiltration from the local—and older—Neanderthal population into the Homo sapiens population.”

    Prof. Hershkovitz noted that modern genetic studies confirm Neanderthal DNA still exists in humans today. “Even today, 40,000 years after the last Neanderthals disappeared, part of our genome—2 to 6 percent—is of Neanderthal origin,” he said. “But these gene exchanges took place much later, between 60,000 to 40,000 years ago. Here, we are dealing with a human fossil that is 140,000 years old.”

    The skull of Skhul I child showing cranial curvature typical of Homo sapiens. Credit – Tel Aviv University

    Rethinking migration timelines

    For decades, scholars believed Neanderthals evolved in Europe and reached Israel only around 70,000 years ago. But recent studies challenge that view.

    In 2021, Prof. Hershkovitz and colleagues described fossils from the Nesher Ramla site dating back 400,000 years. That suggested early Neanderthals lived in the region long before Homo sapiens left Africa. The two groups encountered each other in the Levant about 200,000 years ago.

    The Skhul child provides the earliest direct fossil evidence of their interaction. “The fossil we studied is the earliest known physical evidence of mating between Neanderthals and Homo sapiens,” said Hershkovitz. He compared the finding with the “Lapedo Valley Child” found in Portugal in 1998, which also showed mixed traits but dated to only 28,000 years ago.

    The researchers carried out a detailed morphological analysis by creating 3D models of the skull and jaw.

    These scans also revealed non-visible structures like the inner ear. To map the blood vessel system around the brain, the team produced a full 3D reconstruction of the inside of the skull.

    Traditionally, fossils from the Skhul and nearby Qafzeh caves were classified as early Homo sapiens. The new study shows at least some of them resulted from genetic blending with local Neanderthals.

    According to the researchers, the finding illustrates how ancient populations in the region did not exist in isolation but shaped one another through contact and interbreeding.

    The study is published in the journal l’Anthropologie.

    Continue Reading

  • Sanam Marvi and Ahmed Shah resolve dispute

    Sanam Marvi and Ahmed Shah resolve dispute


    KARACHI:

    An ongoing dispute between renowned singer Sanam Marvi and the President of the Arts Council of Pakistan Karachi, Ahmed Shah, has ended and the two have forgiven each other after clearing up misunderstandings.

    A few days ago, Sanam Marvi had sent a legal notice to Ahmed Shah. The notice alleged that during a Sindh government event in Sukkur on August 10, she was pushed, inappropriate language was used, and threats were made against her.

    The singer had demanded that he apologised within a week or face legal action. Ahmed Shah had denied these allegations, stating that he neither disrespected nor threatened her in any way.

    However, according to Express News, a reconciliation has now been brokered between the two personalities through the intervention of Provincial Minister for Culture, Syed Zulfiqar Ali Shah, and writer Noorul Huda Shah.

    The culture minister shared a video on his Facebook page in which Ahmed Shah referred to Sanam Marvi as a younger sister and daughter, stating that they have a relationship spanning many years and the dispute arose merely from a misunderstanding.

    He acknowledged that the singer was hurt by the inappropriate behaviour of his staff, but all differences have now been resolved. Sanam Marvi also issued a statement in the Sindhi language, saying that according to the traditions of Sindh, she has withdrawn all her allegations.

    She thanked Syed Zulfiqar Ali Shah and Noorul Huda Shah for playing an important role in the reconciliation and said she is grateful to the people of Sindh.

    Continue Reading

  • Why Lionel Messi Isn’t Playing for Inter Miami vs. Tigres

    Why Lionel Messi Isn’t Playing for Inter Miami vs. Tigres

    Inter Miami will face Liga MX side Tigres with a ticket to the 2025 Leagues Cup semifinals on the line, but they’ll have to do so without their best player: Lionel Messi.

    Messi made his return from a minor muscle injury with a goal and an assist in 45 minutes played in Miami’s victory over LA Galaxy last weekend. However, Messi was seen grabbing at his hamstring late in the game, raising concerns over his fitness status.

    Those concerns only worsened when Messi was seen arriving at Chase Stadium ahead of the game vs. Tigres in street clothes. Then, the fears became a reality when Miami announced their starting lineup, with Messi nowhere to be found. The forward is not even available from the bench.

    The Argentine star didn’t feature in Miami’s final practice session prior to the Leagues Cup clash. Javier Mascherano was asked about Messi’s availability on the eve of the game and although he confirmed he didn’t train with the team, he refused to give a definitive answer on his status for the match.

    Lionel Mess

    Lionel Messi was seen grabbing at his hamstring in Miami’s most recent game. / Sam Navarro-Imagn Images

    “Yes, Leo [Messi] didn’t train with the group, he trained separately,” Mascherano said. “He felt uncomfortable in the 45 minutes he played [vs. LA Galaxy]. We’ll monitor him between today and tomorrow, but he’s not ruled out. I can’t tell you right now if he’s going to play or not.

    “A lot of it will depend on how he feels,” Mascherano added.

    Messi suffered the initial injury in Miami’s second game of their 2025 Leagues Cup campaign against Necaxa and had to be substituted 11 minutes into the match. He went on to miss the next two games for the Herons before returning last weekend. However, it now appears his return might’ve been premature.

    Miami started their Leagues Cup journey with a 2–1 win vs. Atlas in a game where Messi had two assists. Now, they’ll be forced to play against one of the strongest sides in North America in the quarterfinals with Messi watching from the stands.

    The club will hope that having Rodrigo De Paul back in the starting XI will help them in their quest to reclaim the Leagues Cup throne they conquered in 2023.

    READ THE LATEST INTER MIAMI NEWS, TRANSFER RUMORS AND MORE

    Continue Reading